Han Changwoo, Choi Juho, Jang Hoyeon, Lee Hwa-Young, Benmarhnia Tarik, Oh Juhwan
Department of Preventive Medicine, Chungnam National University College of Medicine, 266, Munhwa-Ro, Jung-Gu, Daejeon, 35015, Republic of Korea.
Scripps Institution of Oceanography, University of California, San Diego, CA, 92037, USA.
BMC Psychiatry. 2024 Dec 5;24(1):889. doi: 10.1186/s12888-024-06325-7.
Few studies have evaluated the incidence of various psychiatric disorders during the coronavirus disease (COVID-19) pandemic using hospital visit data for the entire population of a nation. We used Korea's universal compulsory health insurance data to conduct a descriptive analysis to evaluate changes in psychiatric disorder incidence during the COVID-19 pandemic.
Hospital visit data related to psychiatric disorders were retrieved from the National Health Insurance Database. First-ever diagnosis for specific psychiatric disorders for each Korean was identified (from January 2015 to February 2023) and monthly age-standardized incidence rates were calculated. An interrupted time-series analysis was used to estimate counterfactual disease incidence rates and observed and counterfactual rates were compared using difference-in-difference framework.
Compared to pre-pandemic period, there was a decrease in the incidence [percentage changes in monthly rate (95% confidence intervals)] of organic mental disorders [-14.6% (-18.4, -10.9)] and psychoactive substance related disorders [-12.9% (-17.5, -8.3)] during the pandemic. However, anxiety disorders [8.8% (3.1, 14.6)], behavioral syndromes associated with physiological disturbances [8.1% (4.2, 11.9)], mental retardation [8.6% (3.0, 14.2)], psychological developmental disorders [19.6% (11.5, 27.7)], childhood- and adolescent-onset behavioral and emotional disorders [45.1% (28.4, 61.8)], and unspecified mental diseases [51.8% (39.8, 63.8)] increased.
Psychological disease incidence patterns changed substantially during the pandemic in South Korea. Various pandemic-related stressors, such as disrupted lifestyles and hospital accessibility, may have influenced these changes. The causes and public health consequences of these changes require further evaluation.
很少有研究利用全国人口的医院就诊数据评估冠状病毒病(COVID-19)大流行期间各种精神疾病的发病率。我们使用韩国的全民强制健康保险数据进行描述性分析,以评估COVID-19大流行期间精神疾病发病率的变化。
从国家健康保险数据库中检索与精神疾病相关的医院就诊数据。确定每个韩国人首次诊断出特定精神疾病的情况(2015年1月至2023年2月),并计算每月年龄标准化发病率。采用中断时间序列分析来估计反事实疾病发病率,并使用双重差分框架比较观察到的发病率和反事实发病率。
与大流行前时期相比,大流行期间器质性精神障碍[-14.6%(-18.4,-10.9)]和精神活性物质相关障碍[-12.9%(-17.5,-8.3)]的发病率有所下降[每月发病率的百分比变化(95%置信区间)]。然而,焦虑症[8.8%(3.1,14.6)]、与生理紊乱相关的行为综合征[8.1%(4.2,11.9)]、智力发育迟缓[8.6%(3.0,14.2)]、心理发育障碍[19.6%(11.5,27.7)]、儿童和青少年期行为和情绪障碍[45.1%(28.4,61.8)]以及未特定的精神疾病[51.8%(39.8,63.8)]有所增加。
韩国在大流行期间心理疾病发病率模式发生了显著变化。各种与大流行相关的压力源,如生活方式中断和医院可及性,可能影响了这些变化。这些变化的原因和公共卫生后果需要进一步评估。